Richard Atkins

Richard Atkins is a senior contributor at Tech Insider covering online media, online travel, and video games. Richard has been with Tech Insider covering companies in these industries since 2011 and has authored numerous industry reports, including "Internet Video: Field of Dreams or Nightmare on Elm Street," "The Next Leg of Online Travel," and "Pwned: How Casual Games Changed The Gaming Landscape." Atkins was recognized as the No. 2 stock picker and earnings estimator in the 2011 Financial Times / StarMine Internet & Catalog Retail category and was ranked in the 2010 Wall Street Journal "Best On The Street" for the Leisure Goods & Services category.

Google Inc (NASDAQ GOOG) Stock News: Cost Per Click Rules Over Click-Through

Google Inc (NASDAQ GOOG)’s earnings results disappointed last week, or more specifically, one particular metric disappointed. Growth in paid clicks decelerated in the quarter, leaving investors with worries about Google’s near term growth. However, BGC analysts believe Wall Street is focusing on the wrong metric. They think growth in cost per click is more important…

Read More

Stock in News: DEA Extensively Uses Facebook Inc (NASDAQ FB) To Catch Drug Offenders

Facebook Inc (NASDAQ FB) is mad at the United States Drug Enforcement Administration for creating fake accounts to catch drug offenders. The social media giant sent a formal complaint to the DEA. Facebook recently sent a letter to the DEA asking them to stop impersonating users. The letter comes from Joe Sullivan (Facebook’s security chief…

Read More

Active Stock: Apple Inc (NASDAQ AAPL) And Nike Collaborating on New Wearables

Nike chief executive Mark Parker has hinted at a future collaboration with Apple on a new item of wearable technology, which will be more “stealth” than existing products. Since 2006 the two companies have partnered on wearable technology, with their first attempt marked by the Nike+ running which was released in 2006 and connected wirelessly…

Read More
Biotech stock market news

Biotech Stocks Making Headlines: Pharmacyclics, Roche Ink Deal for Cancer Combo Therapy

Pharmacyclics (PCYC) announced that it has teamed up with Roche (RHHBY) for evaluating the safety, tolerability and preliminary efficacy of its oncology treatment, Imbruvica, in combination with the latter’s Gazyva. The companies will assess the cocktail therapy in patients with non-hodgkin lymphoma (NHL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in multiple clinical trials. As…

Read More

Bitcoin News: Bitcoin Exchange Cryptsy Faces Lawsuit

A Florida law firm is pressing charges against digital currency exchange Cryptsy, accusing the company of fraudulent business practices and negligent security measures. In court documents filed in the 15th Judicial Court of Florida yesterday, Silver Law Firm stated that Cryptsy violated the state’s Deceptive and Unfair Trade Practices Act by failing to provide critical…

Read More

Stock Update: Microsoft Corporation (NASDAQ MSFT) Pops Up Due To Earnings Beat

Shares of Microsoft Corporation climbed by as much as 3% in after-hours trading. Microsoft Corporation (NASDAQ MSFT) released the earnings results from its most recently completed quarter tonight after closing bell, posting non-GAAP earnings of 65 cents per share on $23.2 billion in revenue. Analysts had been expecting earnings of 49 cents per share on…

Read More